18 Chapter 1 References 1. National Cancer Institute. What Is Cancer?, 2021. Available via: https://www.cancer.gov/ about-cancer/understanding/what-is-cancer. Accessed March 2023. 2. Kanker.nl. Betrouwbare informartie, 2019. Available via: https://www.kanker.nl/. Accessed March 2023. 3. Ferlay J EM, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today Lyon: International Agency for Research on Cancer, 2020. Available via: https://gco.iarc.fr/today/home. Accessed March 2023. 4. World Health Organization. Guide to cancer early diagnosis, 2017. Available via: https:// apps.who.int/iris/handle/10665/254500 . Accessed March 2023. 5. Sung H, Ferlay J, Siegel RL, Laversanne M, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2021;71(3):209-49. 6. World Health Organization. Cancer control: Early detection. WHO guide for effective programmes, 2007. 7. VZinfo.nl. Kanker, 2022. Available via: https://www.vzinfo.nl/kanker. Accessed March 2023. 8. Integraal Kankercentrum Nederland. NKR cijfers, 2022. 9. Perfors I. Eerstelijnszorg voor patiënten met kanker. Huisarts en wetenschap. 2015;58(9):491-. 10. Nielen M, Weesie Y, Davids R, Winckers M, et al. Zorg door de huisarts. Nivel Zorgregistraties Eerst Lijn: jaarcijfers 2020 en trendcijfers 2016-2020. 2021. 11. Nederlands Huisartsen Genootschap. NHG-Standpunt Oncologische zorg in de huisartsenpraktijk, 2014. 12. Korevaar J, Heins M, Donker G, Rijken M, et al. Oncologie in de huisartsenpraktijk. Huisarts en wetenschap. 2013;56(1):6-10. 13. Weller DP, Patnick J, McIntosh HM, Dietrich AJ. Uptake in cancer screening programmes. The lancet oncology. 2009;10(7):693-9. 14. Wilson JMG, Jungner G, World Health O. Principles and practice of screening for disease. Geneva: World Health Organization; 1968. 15. Andermann A, Blancquaert I, Beauchamp S, Déry V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ. 2008;86(4):317-9. 16. Adami H-O, Kalager M, Valdimarsdottir U, Bretthauer M, et al. Time to abandon early detection cancer screening. European Journal of Clinical Investigation. 2019;49(3):e13062. 17. Hochman M, Cohen P. Cancer Screening: No Longer the Default. J Gen Intern Med. 2021;36(2):525-6. 18. Van der Graaf Y. De verhulde risico’s van screening. NtvG, 2022;166:D6760. 19. Hobma S. Wat is uw advies over deelname aan het bevolkingsonderzoek borstkanker? Huisarts en wetenschap. 2019;62(10):38-. 20. Giard RW. Kritische blik op kankerscreening. NtvG, 2022;166:D6926. 21. J. Z. Minister, ik wil een bevolkingsonderzoek. NtvG, 2018;162:C4055. 22. Gini A, Jansen EE, Zielonke N, Meester RG, et al. Impact of colorectal cancer screening on cancer-specific mortality in Europe: a systematic review. European Journal of Cancer. 2020;127:224-35. 23. Jansen EE, Zielonke N, Gini A, Anttila A, et al. Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review. European Journal of Cancer. 2020;127:207-23.
RkJQdWJsaXNoZXIy MTk4NDMw